Henry Schein Inc
F:HS2
Henry Schein Inc
F:HS2
Price:
63.6
EUR
3.21%
Market Closed
Market Cap:
€8.2B
Relative Value
The Relative Value of one
HS2
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 63.6 EUR,
Henry Schein Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HS2 Relative Value
HIDDEN
Multiples Across Competitors
HS2 Competitors Multiples
Henry Schein Inc Competitors
Henry Schein Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Henry Schein Inc
F:HS2
|
9.3B EUR | 0.7 | 24.1 | 11.5 | 16.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
117.1B USD | 0.3 | 29.1 | 20.4 | 23 | |
| US |
|
Cencora Inc
NYSE:COR
|
69.7B USD | 0.2 | 44.8 | 15.1 | 19.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.2B USD | 0.2 | 44.4 | 15 | 19.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.9B USD | 0.2 | 32.4 | 15.6 | 20.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36B AUD | 6 | 67.9 | 51.2 | 51.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.8B CNY | 1.5 | 17.5 | 13.5 | 13.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.4 | 15.3 | 15.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD | 0.1 | 8.6 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.1B USD | 0.8 | 47.6 | 27.4 | 27.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
